Abstract: An intracranial photobiomodulation system (IPS) comprises a removeable light therapy implant and a permanent sheath. The removeable light therapy implant is adapted to be removably secured to the sheath and has (i) a support arm having a proximal end and a distal end, and (ii) at least one light source located along the support arm. The at least one light source is configured to emit light of at least one wavelength and at least one intensity. The permanent sheath comprises a shell and a sleeve. The shell is adapted to be permanently secured to a patient's scalp and the sleeve is made of a transparent material that allows light to pass therethrough and has a proximal opening and a distal closed tip, the proximal opening is adapted to removably receive the support arm and light source of the removeable light therapy implant.

Abstract: A hemostasis valve device includes a valve body having an open first end and an open second end with a main lumen extending from the open first end to the open second end. The valve includes a valve member disposed within the main lumen of the valve body at or proximate to the open first end, the valve member having an open position and a closed position. An actuator is disposed between the valve member and the open second end. The actuator is configured to move the valve member between the open position and the closed position.

Abstract: A method for minimizing infectious particle exposure during endonasal surgeries includes the steps of: introducing an aspiration device through a mouth of a patient and positioning a distal tip within the nasopharynx space, the aspiration device comprising an elongated balloon catheter having an inflatable balloon located within a distal region thereof and a distal aspiration port that is positioned distal to the balloon; inflating the balloon so that the balloon occupies the nasopharynx space; and aspirating any infectious particles within the nasopharynx space via the distal aspiration port.

Abstract: Hemostasis valve devices and methods of use are disclosed. The hemostasis valve devices include a body member, a slide member, an introducer member, a valve cap, and a valve member. The body member and slide member can be gripped by a user's finger and thumb, respectively. The slide member can be distally displaced by the user's thumb to distally displace the introducer member through the valve member to open the valve member to allow passage of a medical appliance through the valve member. The introducer member can be selectively locked in a distal position to keep the valve open.